Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy.

Andereggen, Lukas; Christ, Emanuel (2024). Commentary: Clinical characteristics of male prolactinoma patients mainly presenting with severe obesity and the metabolic response to dopamine agonist therapy. Frontiers in endocrinology, 15 Frontiers Research Foundation 10.3389/fendo.2024.1371468

[img]
Preview
Text
fendo-15-1371468.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (324kB) | Preview

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > Forschungsbereich Mu50 > Forschungsgruppe Neurochirurgie
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurosurgery

UniBE Contributor:

Andereggen, Lukas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1664-2392

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

Pubmed Import

Date Deposited:

27 Mar 2024 10:40

Last Modified:

27 Mar 2024 10:50

Publisher DOI:

10.3389/fendo.2024.1371468

PubMed ID:

38510701

Uncontrolled Keywords:

dopamine agonist male metabolic response obesity prolactinoma

BORIS DOI:

10.48350/194602

URI:

https://boris.unibe.ch/id/eprint/194602

Actions (login required)

Edit item Edit item
Provide Feedback